364 related articles for article (PubMed ID: 20051815)
21. Potential diagnostic utility of CDX-2 immunophenotyping in extramammary Paget's disease.
Zeng HA; Cartun R; Ricci A
Appl Immunohistochem Mol Morphol; 2005 Dec; 13(4):342-6. PubMed ID: 16280663
[TBL] [Abstract][Full Text] [Related]
22. Characteristic Clinicopathological Features of Secondary Extramammary Paget Disease With Underlying Anorectal Adenocarcinoma: Evenly Circumferential Perianal Distribution, Fibroepithelioma of Pinkus-like Changes, and Subepidermal Mucin Deposits Without Invasive Tumor Cells.
Sasaki Y; Goto K; Sugino T; Satake K; Yoshikawa S; Kiyohara Y
Am J Dermatopathol; 2021 Oct; 43(10):721-726. PubMed ID: 33395042
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of CDX2 in the diagnosis of extramammary Paget disease associated with malignancies of intestinal type.
De Nisi MC; D'Amuri A; Toscano M; Lalinga AV; Pirtoli L; Miracco C
Br J Dermatol; 2005 Sep; 153(3):677-9. PubMed ID: 16120171
[No Abstract] [Full Text] [Related]
24. BRAF-mutated microsatellite stable colorectal carcinoma: an aggressive adenocarcinoma with reduced CDX2 and increased cytokeratin 7 immunohistochemical expression.
Landau MS; Kuan SF; Chiosea S; Pai RK
Hum Pathol; 2014 Aug; 45(8):1704-12. PubMed ID: 24908142
[TBL] [Abstract][Full Text] [Related]
25. Use of caveolin-1, thyroid transcription factor-1, and cytokeratins 7 and 20 in discriminating between primary and secondary pulmonary adenocarcinoma from breast or colonic origin.
Tsao SC; Su YC; Wang SL; Chai CY
Kaohsiung J Med Sci; 2007 Jul; 23(7):325-31. PubMed ID: 17606426
[TBL] [Abstract][Full Text] [Related]
26. Expression of CDX2, cytokeratins 7 and 20 in sinonasal intestinal-type adenocarcinoma.
Ortiz-Rey JA; Alvarez C; San Miguel P; Iglesias B; Antón I
Appl Immunohistochem Mol Morphol; 2005 Jun; 13(2):142-6. PubMed ID: 15894926
[TBL] [Abstract][Full Text] [Related]
27. Extramammary Paget disease: Immunohistochemistry is critical to distinguish potential mimickers.
Wang EC; Kwah YC; Tan WP; Lee JS; Tan SH
Dermatol Online J; 2012 Sep; 18(9):4. PubMed ID: 23031371
[TBL] [Abstract][Full Text] [Related]
28. Perianal Paget's disease: a histologic and immunohistochemical study of 11 cases with and without associated rectal adenocarcinoma.
Goldblum JR; Hart WR
Am J Surg Pathol; 1998 Feb; 22(2):170-9. PubMed ID: 9500217
[TBL] [Abstract][Full Text] [Related]
29. [A clinicopathological study of perianal Paget's disease associated with internal rectal adenocarcinoma].
Liu CF; Wang Q; Kong YY; Tu XY; Wang J; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2004 Feb; 33(1):11-5. PubMed ID: 14989921
[TBL] [Abstract][Full Text] [Related]
30. The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody.
Bayrak R; Haltas H; Yenidunya S
Diagn Pathol; 2012 Jan; 7():9. PubMed ID: 22268990
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemistry in the differential diagnosis between primary and secondary intestinal adenocarcinoma of the urinary bladder.
Raspollini MR; Nesi G; Baroni G; Girardi LR; Taddei GL
Appl Immunohistochem Mol Morphol; 2005 Dec; 13(4):358-62. PubMed ID: 16280666
[TBL] [Abstract][Full Text] [Related]
32. Multicentric primary extramammary Paget disease: a Toker cell disorder?
Hashemi P; Kao GF; Konia T; Kauffman LC; Tam CC; Sina B
Cutis; 2014 Jul; 94(1):35-8. PubMed ID: 25101342
[TBL] [Abstract][Full Text] [Related]
33. Expression of the p38 MAPK, NF-kappaB and cyclin D1 in extramammary Paget's disease.
Lin N; Uchi H; Moroi Y; Fukiwake N; Dainichi T; Takeuchi S; Takahara M; Tu Y; Furue M; Urabe K
J Dermatol Sci; 2007 Mar; 45(3):187-92. PubMed ID: 17207971
[TBL] [Abstract][Full Text] [Related]
34. Clinical and pathological characteristics of extramammary Paget's disease: report of 246 Chinese male patients.
Kang Z; Zhang Q; Zhang Q; Li X; Hu T; Xu X; Wu Z; Zhang X; Wang H; Xu J; Xu F; Guan M
Int J Clin Exp Pathol; 2015; 8(10):13233-40. PubMed ID: 26722523
[TBL] [Abstract][Full Text] [Related]
35. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma.
Kennedy MT; Jordan RC; Berean KW; Perez-Ordoñez B
J Clin Pathol; 2004 Sep; 57(9):932-7. PubMed ID: 15333652
[TBL] [Abstract][Full Text] [Related]
36. Primary seminal vesicle carcinoma: an immunohistochemical analysis of four cases.
Ormsby AH; Haskell R; Jones D; Goldblum JR
Mod Pathol; 2000 Jan; 13(1):46-51. PubMed ID: 10658909
[TBL] [Abstract][Full Text] [Related]
37. The value of Cdx2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries.
Groisman GM; Meir A; Sabo E
Int J Gynecol Pathol; 2004 Jan; 23(1):52-7. PubMed ID: 14668551
[TBL] [Abstract][Full Text] [Related]
38. [Detection of CDX-2, CK7 and CK20 in primary and metastatic ovarian carcinoma].
Yuan ZF; Shi HR; Sun HM; Li WC
Zhonghua Bing Li Xue Za Zhi; 2007 Aug; 36(8):555-6. PubMed ID: 17980105
[No Abstract] [Full Text] [Related]
39. Dermoscope-guided lesional biopsy to diagnose EMA+ CK7+ CK20+ extramammary Paget's disease with an extensive lesion.
Chuh A; Zawar V; Fölster-Holst R
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):e92-e94. PubMed ID: 28846155
[No Abstract] [Full Text] [Related]
40. Aberrant cytokeratin expression as a possible prognostic predictor in poorly differentiated colorectal carcinoma.
Yamagishi H; Imai Y; Okamura T; Fukuda K; Ono Y; Ban S; Inoue T; Ueda Y
J Gastroenterol Hepatol; 2013 Dec; 28(12):1815-22. PubMed ID: 23808938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
